Acarviostatin III03

Details

• Internal ID: 074b5b06-e355-4d70-a13f-5e35ab275bea
• Taxonomy: Organic oxygen compounds > Organooxygen compounds > Carbohydrates and carbohydrate conjugates > Aminosaccharides > Aminoglycosides > Aminocyclitol glycosides
• IUPAC Name: (2R,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-5-[(2S,3R,4R,5S,6R)-5-[(2R,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-5-[[(1S,4R,5R,6S)-4-[(2S,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-5-[[(1S,4R,5R,6S)-4-[(2S,3R,4R,5S,6R)-5-[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-5,6-dihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino]-3,4-dihydroxy-6-methyloxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,4-triol
• SMILES (Canonical): CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3C(C(C(C=C3CO)NC4C(OC(C(C4O)O)OC5C(OC(C(C5O)O)OC6C(C(C(C=C6CO)NC7C(OC(C(C7O)O)OC8C(OC(C(C8O)O)OC9C(OC(C(C9O)O)OC1C(OC(C(C1O)O)OC1C(OC(C(C1O)O)O)CO)CO)CO)CO)C)O)O)CO)C)O)O)CO)O)O)NC1C=C(C(C(C1O)O)O)CO
• SMILES (Isomeric): C[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O[C@H]3[C@@H]([C@H]([C@H](C=C3CO)N[C@@H]4[C@H](O[C@@H]([C@@H]([C@H]4O)O)O[C@@H]5[C@H](O[C@@H]([C@@H]([C@H]5O)O)O[C@H]6[C@@H]([C@H]([C@H](C=C6CO)N[C@@H]7[C@H](O[C@@H]([C@@H]([C@H]7O)O)O[C@@H]8[C@H](O[C@@H]([C@@H]([C@H]8O)O)O[C@@H]9[C@H](O[C@H]([C@@H]([C@H]9O)O)O[C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O)O[C@@H]1[C@H](O[C@H]([C@@H]([C@H]1O)O)O)CO)CO)CO)CO)C)O)O)CO)C)O)O)CO)O)O)N[C@H]1C=C([C@H]([C@@H]([C@H]1O)O)O)CO
• InChI: InChI=1S/C75H125N3O52/c1-16-31(76-22-4-19(7-79)34(88)41(95)35(22)89)38(92)51(105)68(114-16)125-62-26(11-83)118-71(54(108)45(62)99)123-59-20(8-80)5-23(36(90)42(59)96)77-32-17(2)115-69(52(106)39(32)93)126-63-27(12-84)119-72(55(109)46(63)100)124-60-21(9-81)6-24(37(91)43(60)97)78-33-18(3)116-70(53(107)40(33)94)127-64-28(13-85)120-74(56(110)47(64)101)129-66-30(15-87)122-75(58(112)49(66)103)130-65-29(14-86)121-73(57(111)48(65)102)128-61-25(10-82)117-67(113)50(104)44(61)98/h4-6,16-18,22-113H,7-15H2,1-3H3/t16-,17-,18-,22+,23+,24+,25-,26-,27-,28-,29-,30-,31-,32-,33-,34-,35+,36+,37+,38+,39+,40+,41+,42-,43-,44-,45-,46-,47-,48-,49-,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73+,74-,75+/m1/s1
• InChI Key: XYBSGFLFCZXVQH-LKAXXFPESA-N
• Popularity: 1 reference in papers

Physical and Chemical Properties

• Molecular Formula: C₇₅H₁₂₅N₃O₅₂
• Molecular Weight: 1900.80 g/mol
• Exact Mass: 1899.7229112 g/mol
• Topological Polar Surface Area (TPSA): 901.00 Ų
• XlogP: -24.70
• Atomic LogP (AlogP): -23.60
• H-Bond Acceptor: 55
• H-Bond Donor: 38
• Rotatable Bonds: 31

Synonyms

There are no found synonyms.

2D Structure

ADMET Properties (via admetSAR 2)

Target	Value	Probability (raw)	Probability (%)
Human Intestinal Absorption	-	0.9754	97.54%
Caco-2	-	0.8617	86.17%
Blood Brain Barrier	-	0.8250	82.50%
Human oral bioavailability	-	0.8714	87.14%
Subcellular localzation	Mitochondria	0.5701	57.01%
OATP2B1 inhibitior	-	1.0000	100.00%
OATP1B1 inhibitior	+	0.8461	84.61%
OATP1B3 inhibitior	+	0.9485	94.85%
MATE1 inhibitior	-	1.0000	100.00%
OCT2 inhibitior	-	0.9500	95.00%
BSEP inhibitior	+	0.8644	86.44%
P-glycoprotein inhibitior	+	0.7376	73.76%
P-glycoprotein substrate	-	0.6081	60.81%
CYP3A4 substrate	+	0.6216	62.16%
CYP2C9 substrate	-	1.0000	100.00%
CYP2D6 substrate	-	0.8060	80.60%
CYP3A4 inhibition	-	0.9488	94.88%
CYP2C9 inhibition	-	0.8751	87.51%
CYP2C19 inhibition	-	0.8569	85.69%
CYP2D6 inhibition	-	0.8805	88.05%
CYP1A2 inhibition	-	0.8952	89.52%
CYP2C8 inhibition	-	0.5853	58.53%
CYP inhibitory promiscuity	-	0.7643	76.43%
UGT catelyzed	+	0.7000	70.00%
Carcinogenicity (binary)	-	0.9700	97.00%
Carcinogenicity (trinary)	Non-required	0.5881	58.81%
Eye corrosion	-	0.9888	98.88%
Eye irritation	-	0.8976	89.76%
Skin irritation	-	0.8104	81.04%
Skin corrosion	-	0.9409	94.09%
Ames mutagenesis	+	0.5100	51.00%
Human Ether-a-go-go-Related Gene inhibition	+	0.8285	82.85%
Micronuclear	+	0.7000	70.00%
Hepatotoxicity	+	0.8875	88.75%
skin sensitisation	-	0.8663	86.63%
Respiratory toxicity	+	0.6667	66.67%
Reproductive toxicity	+	0.8556	85.56%
Mitochondrial toxicity	+	0.8125	81.25%
Nephrotoxicity	-	0.8473	84.73%
Acute Oral Toxicity (c)	III	0.4651	46.51%
Estrogen receptor binding	+	0.7963	79.63%
Androgen receptor binding	+	0.7141	71.41%
Thyroid receptor binding	+	0.6480	64.80%
Glucocorticoid receptor binding	+	0.7130	71.30%
Aromatase binding	+	0.6214	62.14%
PPAR gamma	+	0.7982	79.82%
Honey bee toxicity	-	0.6490	64.90%
Biodegradation	-	0.7500	75.00%
Crustacea aquatic toxicity	-	0.6200	62.00%
Fish aquatic toxicity	-	0.7631	76.31%

Targets

Proven Targets:

CHEMBL ID	UniProt ID	Name	Min activity	Assay type	Source
CHEMBL2045	P04746	Pancreatic alpha-amylase	41.6 nM; 14.3 nM; 14.7 nM	Ki; Ki; Ki	via Super-PRED; via Super-PRED; via Super-PRED
CHEMBL2478	P04745	Salivary alpha-amylase	700 nM	Ki	via Super-PRED

Predicted Targets (via Super-PRED):

CHEMBL ID	UniProt ID	Name	Probability	Model accuracy
CHEMBL5619	P27695	DNA-(apurinic or apyrimidinic site) lyase	98.18%	91.11%
CHEMBL226	P30542	Adenosine A1 receptor	96.31%	95.93%
CHEMBL3251	P19838	Nuclear factor NF-kappa-B p105 subunit	94.47%	96.09%
CHEMBL3401	O75469	Pregnane X receptor	93.45%	94.73%
CHEMBL4016	P42262	Glutamate receptor ionotropic, AMPA 2	91.03%	86.92%
CHEMBL3714130	P46095	G-protein coupled receptor 6	85.81%	97.36%
CHEMBL3476	O15111	Inhibitor of nuclear factor kappa B kinase alpha subunit	85.16%	95.83%
CHEMBL4208	P20618	Proteasome component C5	81.63%	90.00%

Plants that contains it

There are no matching plants.

Cross-Links

• PubChem: 102453872
• LOTUS: LTS0107467
• wikiData: Q105344422